Fischer Medical Ventures Ltd Share Price

Trading

NSE: FISCHER Small Cap ISIN: INE771F01041

As on 18 November 2025 at 23:55 IST

₹47.58

-5.29

(-10.01%)

Sell Buy

Over 1 Month

-43.60%

Over 6 Months

-31.86%

Over 1 Year

None%

Over 3 Years

None%

Fischer Medical Ventures Ltd Summary

Close ₹52.87

Open ₹52.87

High ₹52.87

Low ₹52.87

Volume 2,47,158

Net Turnover (in Cr) ₹1.31

52Wk High ₹124.70

52Wk Low ₹52.87

52Wk High / Low

52.87

124.70

Fischer Medical Ventures Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹3,428.70

EPS (TTM) -

Book Value (BV) 4.77

Div. Yield 0.01 %

P/E (TTM) -5,295

Price/Book Value 11.11

Delivery % 100 %

Face Value 1

Key Ratios

PE Ratio 8,977

PB Ratio 18.75

EV to Sales 1,101.39

PEG Ratio 359.08

ROA 0.18

ROE 0.32

Debt-Equity 0.05

Net Profit Margin 12.64

Operating Profit Margin 23.37

Fischer Medical Ventures Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023
Total Revenue	112.19	21.48	0.18
Total Expenses	109.48	19.37	0.18
Profit Before Tax	2.22	2.11	-0
Profit After Tax	1.21	1.84	-0.04
Operating Profit After Depreciation	3.20	2.18	0.02

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023
Fixed Assets	23.88	14.71	-
Total Non Current Assets	92.08	15.92	0.11
Total Current Assets	365.29	70.41	0.25
Total Assets	457.37	86.32	0.35
Total Shareholder's Fund	337.52	81.11	-0.27

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024
Net Cash From Operating Activities	-86.74	-7.35
Net Cash Used In Investing Activities	-124.87	-28.79
Net Cash Used In Financing Activities	314.92	37.06

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	8.68	12.28	0.18	-	0.17
Total Expenses	7.72	11.74	0.18	0.20	0.20
Profit Before Tax	0.96	0.54	-0	-0.20	-0.04
Profit After Tax	0.66	0.40	-0.04	-0.23	0.14
Operating Profit After Depreciation	1.09	0.55	0.02	-0.19	-0.02

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	0.68	0.01	-	-	-
Total Non Current Assets	330.96	41.29	0.11	0.14	0.18
Total Current Assets	27.55	50.54	0.25	0.05	0.08
Total Assets	358.50	91.83	0.35	0.19	0.25
Total Shareholder's Fund	335.69	79.68	-0.27	-0.23	0

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	-24.10	0.08	-0.15	-0.18	-0.06
Net Cash Used In Investing Activities	-231.79	-37.78	-	-	-
Net Cash Used In Financing Activities	256.18	37.67	0.17	0.15	-

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	86.31	23.44	49.17	11.75	39.66
Total Expenses	70.05	19.18	46.69	11.38	39.16
Profit Before Tax	17.27	10.18	1.80	0.12	0.21
Profit After Tax	13.90	5.01	1.31	-0.29	0.29
Operating Profit after Depreciation	18.74	11.73	2.63	0.75	0.72

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	7.43	4.54	5.22	-	-
Total Expenses	6.29	4.17	6.78	0.21	0.36
Profit Before Tax	1.37	-0.22	-1.13	0.62	0.46
Profit After Tax	0.84	-0.61	-0.89	0.20	0.51
Operating Profit after Depreciation	2.57	1.17	-0.91	0.66	0.46

Fischer Medical Ventures Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 52.87

S2 52.87

S3 52.87

Pivot 52.87

R1 52.87

R2 52.87

R3 52.87

Moving Average

20 SMA 94

50 SMA 102.39

100 SMA -

200 SMA -

Fischer Medical Ventures Ltd Corporate Actions

Fischer Medical Ventures Ltd

₹0.005/Share

Announcement Date 22 Sep 2025

Record Date 22 Sep 2025

Div Yield 0%

AGM Date: 22 Dec 2020

Approved the Notice of 27th Annual General Meeting of the Company to be held on 22nd December, 2020. Outcome of the 27th Annual General Meeting of the Company held on 22nd December, 2020. (As Per BSE Announcement dated on 22.12.2020) Scrutiniser''s report for the 27th Annual General Meeting of the Company. (As per BSE Announcement Dated on 24/12/2020)

AGM Date: 30 Sep 2021

Annual Report of the 28th Annual General Meeting. Outcome of Board Meeting held on 06th September 2021 Proceedings of the 28th Annual General Meeting of the Company (As Per BSE Announcement Dated on 9/30/2021 3:46:29 AM)

AGM Date: 29 Sep 2022

AGM 29/09/2022 Announcement under SEBI Regulation 30 (LODR). (As Per BSE Announcement dated on 05.09.2022) Proceedings of the 29th Annual General Meeting of the Company. (As Per BSE Announcement Dated on 29/09/2022)

AGM Date: 23 Sep 2023

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of the Board of Directors of our Company was held today i.e., on Monday 28th August 2023 at the Registered Office and the Board has considered and approved the notice and Board Report for the financial year ended 31st March 2023. In compliance with the provisions of Regulation 34(1)(a) and other application provisions of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Notice and Annual Report of the Company for the Financial Year 2022-23. (As Per BSE Announcement Dated on 01/09/2023) Submission of proceedings of Annual General Meeting (As Per BSE Announcement Dated on 23/09/2023) Disclosure of E Voting Results (As Per BSE Announcement Dated on 26.09.2023)

AGM Date: 17 Sep 2024

UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30.06.2024 Fischer Medical Ventures Ltd (formerly known as Fischer Chemic Ltd) has informed the exchange on the Proceedings of Annual General meeting of the Company concluded on 17th September 2024 Fischer Medical Ventures Limited has informed the exchange the outcome of AGM concluded on 17/09/2024 (As Per BSE Announcement Dated on 18.09.2024) Proceedings of agm (As Per BSE Announcement Dated on 23.09.2024)

AGM Date: 29 Sep 2025

The 32nd Annual General Meeting ('AGM') of the Members of the Company will be held on Monday, 29th September 2025 through video conferencing or other audio-visual means. The proceedings of the 32nd AGM is enclosed herewith. (As Per Bse Announcement dated on 29/09/2025) Scrutinizer''s Report along with Voting Results are enclosed herewith (As Per BSE Announcement Dated on: 30/09/2025)

EGM Date: 28 Apr 2023

In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable provisions, we wish to inform you that Board of Directors in their meeting held on Thursday 30th March 2023 have inter-alia considered and approved the following amongst other items: 1- The issuance of upto 23,28,000 Equity Shares on private placement & preferential basis ('Preferential Issue') in accordance with sections 23, 42, 62 of the Company Act, 2013 and rule made there under and Chapter V of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 subject to Shareholders approval ('Annexure I') 2- The notice of the Extra-Ordinary General Meeting to be held on 28th April 2023 through Conferencing / other Audio-Visual Means facility for approval of the shareholders. The meeting of Board of Director commences at 5 pm and concluded at 7.30 pm. This is continuation of the outcome of Board Meeting dated 30th March 2023, we wish to inform you that, the Borad has fixed 21st April 2023 as the 'Cut Off Date' for determining the eligibility of the Member to Vote by Electronic means. (As Per BSE Announcement dated on 01.04.2023) Enclose herewith copy of the notice to members dated Thursday 30th March 2023, for holding Extra-Ordinary General Meeting of the Company on Friday 28th April 2023 at 11.30 am (IST) through two-way Video Conferencing (''VC'') facility / Other Audio-Visual Means (''OAVM''). The Company has engaged the services of National Securities Depository Limited for providing the remote e-voting facility to enable members to cast their votes electronically and for two-way Video Conferencing (''VC'') facility / Other Audio-Visual Means (''OAVM''). (As Per BSE Announcement Dated on 05.04.2023) The Company through this communication wishes to bring to the notice of the Shareholders, following changes in the said Extra-Ordinary General Meeting notice dated 30th March 2023. The corrigendum is being circulated today to the shareholders by NSDL and is enclosed herewith for your reference. The corrigendum can also be accessed on the company website on the following link http://www.fischerchemic.in/investor.html This is for the information and records of the Exchanges, please. (As Per BSE Announcement Dated on 25.04.2023) In accordance with Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the voting results of Extra Ordinary General Meeting of the Company held on 28th April 2023 in the prescribed format along with the report of the Scrutinizer on remote e-voting and e-voting at the Extra Ordinary General Meeting Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith proceedings of the of Extra-Ordinary General Meeting (EOGM) of the Company held on Friday 28th April 2023 at 11:30 a.m., through Video Conferencing ('VC')/ Other Audio-Visual Means ('OAVM'). (As Per BSE Announcement Dated on 28.04.2023) Disclosure under Regulation 30 of SEBI LODR Regulations 2015-Allotment of Equity Shares. (As Per BSE Announcement Dated on 29.06.2023)

EGM Date: 13 Jan 2024

In terms of Regulation 30 of SEBI LODR Regulations 2015 please find enclosed outcome of the Board Meeting held on 15th December 2023 for your knowledge and information. Book Closure for EGM (As Per BSE Announcement dated on 18.12.2023) Proceedings of the Extra Ordinary General Meeting held on 13th January 2024. Proceedings of Extra Ordinary General Meeting. Voting Results and Scrutinizer Report under Regulation 44 (As Per BSE Announcement Dated on 13.01.2024)

EGM Date: 31 Jan 2025

The 1st Extra-Ordinary General Meeting ('EGM') of the Members of the Company for the Financial Year 2024-2025 will be held on Friday, January, 31, 2025 through video conferencing or other audio-visual means at 11.00 AM. Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on Extra Ordinary General Meeting scheduled on January 31, 2025 and Book Closure and record date for the same (As Per Bse Announcement Dated on 09.01.2025) Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on the Proceedings of the Extra Ordinary General Meeting concluded on January 31, 2025 (As Per BSE Announcement dated on 31.01.2025) Fischer Medical Ventures Limited has informed the exchange on the Voting results and scrutinizer report in respect of 1st EGM for the FY 2024 - 2025 concluded on 31st January 2025 (As Per BSE Announcement Dated on 02/02/2025)

Fischer Medical Ventures Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Adani Enterprises Ltd	₹2,464.90	₹3,18,633.29
Premier Energies Ltd	₹1,015.45	₹45,999.31
Aegis Logistics Ltd	₹797.60	₹27,995.76
Redington Ltd	₹296.50	₹23,179.61
RRP Semiconductor Ltd	₹11,549.95	₹15,735.65

Fischer Medical Ventures Ltd Top Mutal Funds Invested

Fund Name	AUM
Bandhan BSE Healthcare Index Fund	0.09%

Fischer Medical Ventures Ltd News

Fischer Medical Ventures arm wins order of Rs 9.29 cr

From Tamil Nadu Animal Husbandry Department

13 Nov 2025, 10:03 am

Fischer Medical Ventures Ltd leads losers in 'B' group

Fineotex Chemical Ltd, Blue Jet Healthcare Ltd, G K P Printing & Packaging Ltd and DJ Mediaprint & Logistics Ltd are among the other losers in the BSE's 'B' group today, 04 November 2025.

04 Nov 2025, 02:45 pm

Fischer Medical Ventures spurts after strong Q2 performance

Fischer Medical Ventures jumped 7.70% to Rs 117.50 after the company's consolidated net profit surged to Rs 13.89 crore in Q2 FY26 from Rs 0.23 crore posted in Q2 FY25.

29 Oct 2025, 10:04 am

Fischer Medical Ventures to conduct board meeting

On 28 October 2025

23 Oct 2025, 05:26 pm

Fischer Medical Ventures revises Final Dividend

Post Stock Split

20 Sep 2025, 10:02 am

Fischer Medical Ventures Ltd Stock Analysis

Annual revenue for Fischer Medical Ventures Ltd decreased by 29.34% to ₹8.68 crore in FY 2025 from ₹12.28 crore in FY 2024.
Annual Net Profit for Fischer Medical Ventures Ltd increased by 64.65% to ₹0.66 crore in FY 2025 from ₹0.40 crore in FY 2024.
Promoter Shareholding in Fischer Medical Ventures Ltd remains unchanged by 0.00% in the most recent quarter, from 61.80% in September 2025 to 61.80% in September 2025.
Fischer Medical Ventures Ltd delivered a 1-year return of 0% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
Fischer Medical Ventures Ltd share price moved down by 10.01% from its previous close of INR ₹52.87. The latest Fischer Medical Ventures Ltd share price is INR ₹47.58.
Fischer Medical Ventures Ltd share price today has been at a low of 47.58 and a high of 47.58. Over the past 52 weeks, the Fischer Medical Ventures Ltd share price has seen a low of 47.58 and a high of 124.70.